Table 7.
Pretreatment/Extraction Protocol | Average of Ct Values ± Standard Deviation | ||
---|---|---|---|
100 oocysts/mL | 500 oocysts/mL | 1000 oocysts/mL | |
QF | 37.60 a ± 1.03 | 35.99 ± 0.84 | 35.27 ± 0.84 |
IN | 35.70 b ± 0.94 | 33.13 ± 0.23 | 32.66 ± 0.28 |
MP | 34.20 c ± 0.45 | 33.23 ± 0.44 | 33.46 ± 0.57 |
MPG | 34.30 ± 0.81 | 30.86 ± 0.25 | 31.11 ± 0.48 |
EM | 33.60 ± 0.48 | 31.53 ± 0.32 | 30.86 ± 0.31 |
QP | 33.54 ± 0.39 | 31.48 ± 0.24 | 29.88 ± 0.20 |
ZR | 31.91 ± 0.18 | 29.86 ± 0.16 | 28.89 ± 0.37 |
a, average calculated on 9 values of Ct; b, average calculated on 16 values of Ct; c, average calculated on 15 values of Ct; QF, QIAamp Fast DNA Stool Mini Kit®, Qiagen; MP, MagnaPure 96® without grinding, Roche Diagnostics; IN, ELITE InGenius®, ELITechGroup; MPG, MagnaPure 96® with grinding, Roche Diagnostics; EM, Nuclisens® EasyMAG®, bioMérieux; QP, QIAamp Power Fecal DNA Kit®, Qiagen; ZR, Quick DNA Fecal/Soil Microbe Miniprep®, ZymoResearch.